244 related articles for article (PubMed ID: 9649657)
21. Lepromatous and tuberculoid leprosy: clinical presentation and cytokine responses.
Ochoa MT; Valderrama L; Ochoa A; Zea A; Escobar CE; Moreno LH; Falabella R
Int J Dermatol; 1996 Nov; 35(11):786-90. PubMed ID: 8915730
[TBL] [Abstract][Full Text] [Related]
22. M. leprae- and BCG-induced chemiluminescence response of monocytes from leprosy patients and healthy subjects: effects of gamma-interferon and GM-CSF.
Launois P; Blum L; Dieye A; Millan J; Sarthou JL; Michel JC; Bach MA
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):582-9. PubMed ID: 1802941
[TBL] [Abstract][Full Text] [Related]
23. Immunological profile of treated lepromatous leprosy patients.
Joshi B; Girdhar BK; Mohanty KK; Beuria MK; Girdhar A; Sengupta U
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):195-203. PubMed ID: 11875763
[TBL] [Abstract][Full Text] [Related]
24. Presence of intestinal helminths decreases T helper type 1 responses in tuberculoid leprosy patients and may increase the risk for multi-bacillary leprosy.
Diniz LM; Magalhães EF; Pereira FE; Dietze R; Ribeiro-Rodrigues R
Clin Exp Immunol; 2010 Jul; 161(1):142-50. PubMed ID: 20491787
[TBL] [Abstract][Full Text] [Related]
25. Development of giant reaction in response to PPD skin test in lepromatous leprosy patients.
Sampaio EP; Duppre NC; Nery JA; Moreira AL; Sarno EN
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):205-13. PubMed ID: 8371029
[TBL] [Abstract][Full Text] [Related]
26. Analysis of circulating immune complexes from leprosy patients for Mycobacterium leprae antigens.
Sinha S; Chaturvedi V; Mishra B; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):396-403. PubMed ID: 1282143
[TBL] [Abstract][Full Text] [Related]
27. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients.
Chattree V; Khanna N; Rao DN
Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060
[TBL] [Abstract][Full Text] [Related]
28. Depressed interleukin-12 production by peripheral blood mononuclear cells after in vitro stimulation with the 30-kDa antigen in recurrent pulmonary tuberculosis patients.
Lee JS; Song CH; Kim CH; Kong SJ; Shon MH; Suhr JW; Jung SS; Lim JH; Kim HJ; Park JK; Paik TH; Jo EK
Med Microbiol Immunol; 2003 May; 192(2):61-9. PubMed ID: 12736818
[TBL] [Abstract][Full Text] [Related]
29. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
Mohanty KK; Joshi B; Katoch K; Sengupta U
Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
[TBL] [Abstract][Full Text] [Related]
30. Dharmendra antigen but not integral M. leprae is an efficient inducer of immunostimulant cytokine production by human monocytes, and M. leprae lipids inhibit the cytokine production.
Nakamura C; Fukutomi Y; Kashiwabara Y; Oomoto Y; Kojima M; Hayashi H; Onozaki K
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):63-72. PubMed ID: 9207755
[TBL] [Abstract][Full Text] [Related]
31. Lymphoproliferation and in vitro antibody synthesis in leprosy patients.
Yandava CN; Bhutani LK; Sharma AK; Nath I
Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):633-40. PubMed ID: 2674302
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor (TNF) production in leprosy patients.
Kaur I; Agnihotri N; Mehta M; Dogra S; Ganguly NK
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):249-50. PubMed ID: 11875771
[No Abstract] [Full Text] [Related]
33. Cytokines in mycobacterial infections: in vitro and ex vivo studies.
Flad HD; Gercken J; Hübner L; Schlüter C; Pryjma J; Ernst M
Arch Immunol Ther Exp (Warsz); 1995; 43(2):153-8. PubMed ID: 8744732
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the immune deficit in leprosy patients and the effect of recombinant IL-2 in vitro.
Locniskar M; McEniry DW; Mudd DW; Rose P; Lucas DC; Larrick J; McAdam KP
Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):249-60. PubMed ID: 3298472
[TBL] [Abstract][Full Text] [Related]
35. Cellular and humoral immune responses to recombinant 65-kD antigen of Mycobacterium leprae in leprosy patients and healthy controls.
Ilangumaran S; Shanker Narayan NP; Ramu G; Muthukkaruppan VR
Clin Exp Immunol; 1994 Apr; 96(1):79-85. PubMed ID: 8149671
[TBL] [Abstract][Full Text] [Related]
36. A role for IL-12 receptor expression and signal transduction in host defense in leprosy.
Kim J; Uyemura K; Van Dyke MK; Legaspi AJ; Rea TH; Shuai K; Modlin RL
J Immunol; 2001 Jul; 167(2):779-86. PubMed ID: 11441083
[TBL] [Abstract][Full Text] [Related]
37. Cytokines as biomarkers to monitoring the impact of multidrug therapy in immune response of leprosy patients.
Cassirer-Costa F; Medeiros NI; Chaves AT; Lyon S; Coelho-Dos-Reis JGA; Ribeiro-Junior AF; Correa-Oliveira R; Rocha MOC; Gomes JAS
Cytokine; 2017 Sep; 97():42-48. PubMed ID: 28570932
[TBL] [Abstract][Full Text] [Related]
38. Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.
Goulart IM; Mineo JR; Foss NT
Clin Exp Immunol; 2000 Dec; 122(3):330-4. PubMed ID: 11122237
[TBL] [Abstract][Full Text] [Related]
39. Mitogen induced proliferation and cytokine production by lymphocytes from leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Acta Leprol; 1991; 7(5):397-402. PubMed ID: 1805495
[TBL] [Abstract][Full Text] [Related]
40. Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis.
De A; Blotta HM; Mamoni RL; Louzada P; Bertolo MB; Foss NT; Moreira AC; Castro M
J Rheumatol; 2002 Jan; 29(1):46-51. PubMed ID: 11824970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
